Background Image
Table of Contents Table of Contents
Previous Page  28 / 52 Next Page
Information
Show Menu
Previous Page 28 / 52 Next Page
Page Background

RESEARCH ARTICLE

SA JOURNAL OF DIABETES & VASCULAR DISEASE

78

VOLUME 13 NUMBER 2 • DECEMBER 2016

isonitrile (99mTc-MIBI), the patients were given one to two tablets

of sublingual nitroglycerin (0.4 mg), five minutes apart and they

were injected with 740 MBq (20 mCi) of MIBI. A GSPECT study was

performed 45 minutes later.

GSPECT data were acquired in the supine position with the

double-head SPECT-

γ

camera equipped with a high-resolution low-

energy collimator. The obtained data were projected as myocardial

tomographic slices in short-axis, vertical long-axis and horizontal

long-axis views. Electrocardiogram gating was applied to the

cardiac cycle with eight frames per cardiac cycle. The myocardium

was divided into 17 segments following the American Society

of Nuclear Cardiology/American College of Cardiology/American

Heart Association guidelines.

8

GSPECT dates were processed and analysed using 4D-MSPECT

software, which determines the extent and severity of left ventricular

perfusion defect size and the extent of reversible (ischaemia) or fixed

(scar) perfusion defects.

9

The programme assigned a score of 0 to 4

to each segment based on activity level: 0 = normal, 1 = equivocal,

2 = moderate, 3 = severe reduction of radioisotope uptake, and 4 =

absence of detectable tracer uptake. Abnormal perfusion, motion

and thickening were defined as a score of ≥ 2.

The summed stress score (SSS), summed rest score (SRS), and

summed difference score (SDS) were calculated based on the

conventional 17-segment model. The summed difference score

(SDS), indicating the extent of reversible perfusion defects, was

obtained by calculating the differences between the SSS and SRS.

Statistical analysis

Statistical analyses were performed using SPSS 18.0 software.

Parametric values are given as mean ± standard deviation and

non-parametric values as a percentage. To compare parametric

continuous variables, the Student’s

t

-test was used; to compare

non-parametric continuous variables, the Mann-Whitney

U

-test was

used. Categorical data were compared by chi-square distribution.

Stepwise multivariate logistic regression models were created to

determine independent variables for myocardial perfusion defect.

For multivariate regression, variables with a

p

-value < 0.1 in

univariate analysis were selected. Two-tailed

p

-values < 0.05 were

considered to indicate statistical significance.

Results

Baseline characteristic of the patients are given in Table 1. Levels

of glucose, triglycerides (TG), total cholesterol (TC), low-density

lipoprotein (LDL) cholesterol, high-density lipoprotein (HDL)

cholesterol, haemoglobin (Hb) and glycosylated haemoglobin

(HbA

1c

), and body mass index (BMI) in the two groups were not

statistically significantly different. The MPV level was higher in

group 1 than in group 2 patients (8.76 ± 0.78 and 8.25 ± 0.78

fl, respectively,

p

= 0.003). Levels of MPV in the two groups are

shown in Fig. 1.

Univariate analysis showed that MPV, and HbA

1c

and glucose

levels were significantly involved in myocardial perfusion defects.

Multivariate logistic regression analyses showed that MPV was the

only variable independently associated with myocardial perfusion

defect (OR: 2.401, 95% CI: 1.298-4.440,

p

= 0.013) (Table 2).

Discussion

This study showed that there was a relationship between myocardial

perfusion defect and MPV. MPV was higher in the group with

myocardial perfusion defects, compared to the one without

myocardial perfusion defects. Patients with diabetes develop

vascular complications, including macrovascular complications

[coronary artery disease (CAD), peripheral vascular disease and

stroke] andmicrovascular complications [diabetic nephropathy (DN),

diabetic retinopathy (DR) and peripheral neuropathy].

10

Continuous

hyperglycaemia may cause endothelial dysfunction and vascular

lesions, resulting in diabetic vascular complications.

11,12

Type 2 diabetes is a substantial risk factor in atherosclerotic

cardiovascular disease.

13,14

Cardiovascular disease (CVD) is the

leading cause of death in patients with type 2 DM.

15

Asymptomatic

CAD is common in patients with DM and is a strong predictor of

future poor outcome of coronary vascular events, as well as early

death.

16,17

DM is associated with generalised endothelial dysfunction

and small-vessel abnormalities.

18,19

Perfusion defects are substantial predictors of coronary events in

patients with known or suspected coronary heart disease (CHD).20

It is proposed that concomitant abnormalities of perfusion imaging

scans in patients with diabetes with normal coronary angiograms

Table 1.

Baseline characteristic of the patients.

Group 1

Group 2

p

–value

Age (years)

60.02 ± 9.28

60.81 ± 8.02

0.660

Women (%)

72.7

68.2

0.408

HT (%)

72.7

86.4

0.093

HL (%)

47.7

56.8

0.281

Aspirin (%)

34.1

29.5

0.410

BMI (kg/m

2

)

31.41 ± 6.23

30.41 ± 5.7

0.446

Glucose (mg/dl)

131.79 ± 40.553

151.16 ± 54.213

0.070

TG (mg/dl)

192.36 ± 116.48

171.71 ± 87.321

0.600

TC (mg/dl)

190.04 ± 42.25

178.83 ± 46.73

0.258

HDL-C (mg/dl)

40.58 ± 5.911

38.68 ± 6.08

0.167

LDL-C (mg/dl)

118.77 ± 28.75

108.28 ± 33.82

0.133

Hb (g/dl)

13.16 ± 1.40

13.42 ± 1.46

0.399

MPV (fl)

8.76 ± 0.76

8.25 ± 0.78

0.003

HbA

1c

(%)

8.67 ± 0.68

8.35 ± 0.86

0.094

HT: hypertension; HL: hyperlipidaemia TG: triglycerides; TC: total

cholesterol; HDL-C: high-density lipoprotein cholesterol; LDL-C: lowdensity

lipoprotein cholesterol; Hb: haemoglobin; MPV: mean platelet

volume; HbA

1c

: glycosylated haemoglobin.

Fig. 1.

MPV levels in the two groups.